News
Recursion Pharmaceuticals bets on REC-4881, cancer candidates and new hypophosphatasia therapy to rebuild momentum after key drug cuts rattled investors.
Mixture-of-Recursions (MoR) is a new AI architecture that promises to cut LLM inference costs and memory use without ...
As of July 22, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as ...
Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to buy according to analysts. On July 8, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results